Cutaneous leishmaniasis. Cutaneous leishmaniasis
Conditions
Interventions
Patients will use the topical product containing 5% Myrrh gum in the standard base cream prepared in the comprehensive pharmaceutical laboratory twice a day on the skin lesions in an amount that compl
Sponsors
Kerman University of Medical Sciences
Eligibility
Sex/Gender
All
Age
8 Years to 60 Years
Inclusion criteria
Inclusion criteria: Cutaneous leishmaniasis by leishmania major Number of skin lesions less than 5 Ulcer size less than 5 cm Duration of lesions no more than 3 months Receiving no anti-leishmania treatment remedies during the past 3 months Completing the informed consent form
Exclusion criteria
Exclusion criteria: Pregnancy and lactation Underlying diseases and allergy Lesions on joints, face and sensitive organs Regional adenopathy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Size of Leishmania lesion. Timepoint: in 0,1,2,3,4,6,8 weeks of treatment. Method of measurement: WoundDesk app.;Induration of lesion. Timepoint: in 0,1,2,3,4,6,8 weeks of treatment. Method of measurement: Digital Caliper.;Wound healing time. Timepoint: in 0,1,2,3,4,6,8 weeks of treatment. Method of measurement: Counting of weeks. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMehdi Shafiei_bafti
Kerman University of Medical Sciences
Outcome results
None listed